Literature DB >> 11371109

Long-term outcome of kidney transplantation in adult recipients with focal segmental glomerulosclerosis.

K H Choi1, S I Kim, S Y Yoon, J H Kim, S W Kang, S K Ha, H Y Lee, D S Han, Y S Kim, K Park, H J Jeong, D K Kim.   

Abstract

Focal segmental glomerulosclerosis (FSGS) is an important cause of nephrotic syndrome and end-stage renal disease. FSGS recurrence after renal transplantation has a potentially detrimental course leading to the loss of renal function. In order to establish FSGS recurrence rates and evaluate the course of the disease on living-related-donor renal transplantation in ethnic Korean adults (> or = 18 years), we reviewed our experiences of 27 kidney transplantations with FSGS over the last 15 years. Of the 27 renal allografts, 13 were found to have recurrent FSGS by graft biopsy. In comparison with background data upon patients with and without recurrence of FSGS, the donor age of patients with recurrent FSGS was significantly higher than that of those without recurrence (median, 39 years vs 26, p < 0.05). In terms of, age at transplantation, length of dialysis period, and mode of dialysis no differences were found between recurrent and nonrecurrent cases. The graft survival rate of recipients from a kidney donor of age less than 40 years was significantly higher than that of recipients from a kidney donor of age more than 40 years, at 5 and 10 years, respectively (87% vs 33%, 41% vs 0%, p < 0.05). The association between clinical variables and recurrence was assessed by multiple logistic regression analysis, and donor age was found to be a risk factor of FSGS recurrence (p<0.05). Variables such as HLA-mismatch numbers and immunosuppression were not found to be associated. In conclusion, the recurrence rate of FSGS in adult recipients with FSGS was 48% and patients that received kidney from an older donor appear to be at higher risk of developing recurrence. The use of a renal graft from a younger donor is considered advisable for adult recipients with FSGS.

Entities:  

Mesh:

Year:  2001        PMID: 11371109     DOI: 10.3349/ymj.2001.42.2.209

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  4 in total

1.  Long-Term Outcome of Kidney Transplantation in Recipients with Focal Segmental Glomerulosclerosis.

Authors:  Anna Francis; Peter Trnka; Steven J McTaggart
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-20       Impact factor: 8.237

2.  Recurrence of FSGS after Kidney Transplantation in Adults.

Authors:  Audrey Uffing; Maria José Pérez-Sáez; Marilda Mazzali; Roberto C Manfro; Andrea Carla Bauer; Frederico de Sottomaior Drumond; Michelle M O'Shaughnessy; Xingxing S Cheng; Kuo-Kai Chin; Carlucci G Ventura; Fabiana Agena; Elias David-Neto; Juliana B Mansur; Gianna Mastroianni Kirsztajn; Helio Tedesco-Silva; Gilberto M V Neto; Carlos Arias-Cabrales; Anna Buxeda; Mathilde Bugnazet; Thomas Jouve; Paolo Malvezzi; Enver Akalin; Omar Alani; Nikhil Agrawal; Gaetano La Manna; Giorgia Comai; Claudia Bini; Saif A Muhsin; Miguel Carlos Riella; Silvia R Hokazono; Samira S Farouk; Meredith Haverly; Suraj Sarvode Mothi; Stefan P Berger; Paolo Cravedi; Leonardo V Riella
Journal:  Clin J Am Soc Nephrol       Date:  2020-01-23       Impact factor: 8.237

3.  Effects of pretransplant plasmapheresis and rituximab on recurrence of focal segmental glomerulosclerosis in adult renal transplant recipients.

Authors:  Hoon Suk Park; Yuah Hong; In O Sun; Byung Ha Chung; Hyung Wook Kim; Bum Soon Choi; Cheol Whee Park; Dong Chan Jin; Yong Soo Kim; Chul Woo Yang
Journal:  Korean J Intern Med       Date:  2014-06-27       Impact factor: 2.884

Review 4.  Recurrent Glomerulonephritis after Renal Transplantation: The Clinical Problem.

Authors:  Barbara Infante; Michele Rossini; Serena Leo; Dario Troise; Giuseppe Stefano Netti; Elena Ranieri; Loreto Gesualdo; Giuseppe Castellano; Giovanni Stallone
Journal:  Int J Mol Sci       Date:  2020-08-19       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.